Evaluation of outcome of otitis media after lavage of the tympanic bulla and long-term antimicrobial drug treatment in dogs: 44 Cases (1998-2002)

Journal of the American Veterinary Medical Association

Volumn 225, Issue 4, 2004, Pages 548-553

  Palmeiro, Brian S ^a   Morris, Daniel O ^a   Wiemelt, Staci P ^a   Shofer, Frances S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL THERAPY; AUDITORY CANAL; BACTERIUM CULTURE; BLISTER; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTODIAGNOSIS; DOG; EARDRUM; FOLLOW UP; LAVAGE; MEDICAL RECORD; NONHUMAN; OTITIS MEDIA; OTOSCOPY; OUTCOMES RESEARCH; PATIENT REFERRAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; REVIEW; SKIN DISEASE; STATISTICAL ANALYSIS; STREPTOCOCCUS INTERMEDIUS; TYMPANIC BULLA; VIDEOOTOSCOPY;

ANIMALS; ANTI-BACTERIAL AGENTS; DOG DISEASES; DOGS; EAR CANAL; FEMALE; IRRIGATION; MALE; OTITIS MEDIA; OTOSCOPY; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; BACTERIA (MICROORGANISMS); BULLA; CANIS FAMILIARIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS; STREPTOCOCCUS INTERMEDIUS;

EID: 4043162954     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.225.548     Document Type: Review

References (33)

1. Cole LK, Kwochka KW, Kowalski JJ, et al. Microbial flora and antimicrobial susceptibility patterns of isolated pathogens from the horizontal ear canal and middle ear in dogs with otitis media. J Am Vet Med Assoc 1998;212:534-538.
2. Gotthelf LN. Secondary otitis media-an often overlooked condition. Canine Pract 1995;20(1):14-20.
3. Shell LG. Otitis media and otitis interna: etiology, diagnosis, and medical management. Vet Clin North Am Small Anim Pract 1988; 18:885-899.
4. Spreull JSA. Treatment of otitis media in the dog. J Small Anim Pract 1964;5:107-152.
5. Little CJL, Lane JG, Pearson GR. Inflammatory middle ear disease of the dog: the pathology of otitis media. Vet Rec 1991;128:293-296.
6. August JR. Otitis externa: a disease of multifactorial etiology. Vet Clin North Am Small Anim Pract 1988;18:731-742.
7. Cole LK, Kwochka KW, Podell M, et al. Evaluation of radiography, otoscopy, pneumotoscopy, impedance audiometry and endoscopy for the diagnosis of otitis media in the dog. In: Thoday KL, Foil CS, Bond R, eds. Advances in veterinary dermatology. Vol 4. Oxford, UK: Blackwell Science Ltd, 2002;49-54.
8. Bensignor E. An approach to otitis externa and otitis media. In: Foster C, Foil C, eds. BSAVA manual of small animal dermatology. 2nd ed. Gloucester, UK: British Small Animal Veterinary Association, 2003;104-111.
9. Logas D. Ear flushing techniques and therapeutic importance. In: Bonagura JD, ed. Kirk's current veterinary therapy XIII. Small animal practice. Philadelphia: WB Saunders Co, 2000;585-586.
10. Willemse A. Atopic skin disease: a review and reconsideration of diagnostic criteria. J Small Animal Pract 1986;27:771-778.
11. Gotthelf LN. Diagnosis and treatment of otitis media in dogs and cats. Vet Clin North Am Small Anim Pract 2004;34:469-487.
12. Brothers AM, Gibbs PS, Wooley RE. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro. Vet Ther 2002;3: 493-500.
13. Plumb DC. Drug monographs (various). In: Veterinary drug handbook. 4th ed. Ames, Iowa: Iowa State Press, 2002.
14. Lloyd DH. Antibiotic resistance. The challenge in small animal dermatology, in Proceedings. Br Vet Dermatol Study Group Spring Meet 1998;8-11.
15. Hariharan H, McPhee L, Heaney S, et al. Antimicrobial drug susceptibility of clinical isolates of Pseudomonas aeruginosa. Can Vet J 1995;36:166-168.
16. Barassa JLM, Gomez PL, Lama ZG, et al. Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa. J Vet Med 2000;47:191-196.
17. Pellerin JL, Bourdeau P, Sebbag H, et al. Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedium clinical isolates from canine pyodermas. Comp Immunol Microbiol Infect Dis 1998;21:115-133.
18. Lilenbaum W, Veras M, Blum E, et al. Antimicrobial susceptibility of staphylococci isolated from otitis externa in dogs. Lett Appl Microbiol 2000;31:42-45.
19. Berger-Bachi B, Rohrer S. Factors influencing methicillin resistance in staphylococci. Arch Microbiol 2002;178:165-171.
20. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol RCT 1997;10:781-791.
21. Bidgood T, Papich MG. Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogs. Am J Vet Res 2002;63:1622-1628.
22. Papich MG. Antibacterial drug therapy. Clin Pharmacol Ther 1998;28:215-231.
23. Moore KW, Trepanier LA, Lautzenhiser SJ, et al. Pharmacokinetics of ceftazidime in dogs following subcutaneous administration and continuous infusion and the association with in vitro susceptibility of Pseudomonas aeruginosa. Am J Vet Res 2000;61:1204-1208.
24. Hoffman S. Silver sulfadiazine: an antibacterial agent for topical use in burns. Scand J Plast Reconstr Surg 1984;18:119-126.
25. Kjolseth D, Frank JM, Barker JH, et al. Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. J Am Coll Surg 1994;179:305-312.
26. Lansdown AB, Sampson B, Laupattarakasem P, et al. Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat. Br J Dermatol 1997;137:728-735.
27. Marone P, Monzillo V, Perversi L, et al. Comparative in vitro activity of silver sulfadiazine, alone or in combination with cerium nitrate, against staphylococci and gram-negative bacteria. J Chemother 1998;10:17-21.
28. Schmidt A. In vitro activity of climbazole, clotrimazole, and silver sulphadiazine against isolates of Malassezia pachydermatis. Zentralbl Veterinarmed [B] 1997;44:193-197.
29. Modak SM, Fox CL. Sulfadiazine silver-resistant Pseudomonas in burns. New topical agents. Arch Surg 1981;116: 854-857.
30. Boothe HW. Surgical management of otitis media and otitis interna. Vet Clin North Am Small Anim Pract 1988;18:901-911.
31. Beckman SL, Henry WB Jr, Cechner P. Total ear canal ablation combining bulla osteotomy and curettage in dogs with chronic otitis externa and media. J Am Vet Med Assoc 1990;196:84-89.
32. Sharp NJ. Chronic otitis externa and otitis media treated by total ear canal ablation and ventral bulla osteotomy in thirteen dogs. Vet Sur 1990;19:162-166.
33. Krahwinkel DJ, Pardo AD, Sims MH, et al. Effect of total ablation of the external acoustic meatus and bulla osteotomy on auditory function in dogs. J Am Vet Med Assoc 1993;202:949-952.